PAH: Clinical Trials

1 trial for PAH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Enrolling by invitation 1

Follow PAH: new trials by email Literature Review of PAH trials Research Report on PAH

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Ralinepag - PAH, Pulmonary Hypertension
Phase 3Enrolling by invitationUnited Therapeutics10002019-09-232026-10-06

Narrower conditions

Cardiovascular Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Lung Diseases (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)

Broader conditions

Skin and Connective Tissue Diseases (1)

Interventions

ralinepag (1)

Sponsors

United Therapeutics (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)